Skip to main navigation Skip to search Skip to main content

Interferon-α treatment of patients with hepatitis C: The role of a comprehensive risk-benefit assessment (multiple letters)

  • Muhamad Aly Rifai
  • , Jennifer M. Loftis
  • , Peter Hauser
  • , Charles L. Raison
  • , Marina Demetrashvili
  • , Lucile Capuron
  • , Andrew H. Miller

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)719-721
Number of pages3
JournalCNS Drugs
Volume19
Issue number8
DOIs
StatePublished - 2005

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this